1Shepherd FA,Giaccone G,Seymour L,et al.Prospective,random-ized,double-blind placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer:a trial of the national cancer institute of Canada-clinical trials group and the European organization for research and treatment of cancer[J].Clin Oncol ,2002,20(22):4434-4439.
2Frances A,Shepherd,Srikala SS.Angiogenesis inhibitors under study for the treatment of lung cancer[J].Lung Cancer,2003,41,63-72.
4Tolcher AW,O'Leary J,DeBono JS,et al.A phase I and biologic correlative study of an oral endothelial vascular growth factor receptor-2(VEGFR-2) tyrosine kinase inhibitor,CP-547,632 in patients with advanced solid tumors[J].Proc ASCO,2002,21:84.
5[1]Clavel G,Bessis N,Lemeiter D,et al.Angiogenesis markers(VEGF,soluble receptor of VEGF and angiopoietin-1)in very early arthritis and their association with inflammation and joint destruction[J].Clinical Immunology,2007,124(2):158-164.
6[3]Giatromanolaki A,Sivridis E,Maltesos E,et al,Upregulated hypoxia inducible factor-1 alpha and 2-alpha pathway in rheumatoid arthritis and oeleoarthritis[J].Arthritis Res Ther,2003,5(4):193-201.
7[5]Christian S,Haas M.Asif Amin,et al.Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis[J].Arhtritis and Rheumatism,2006,54(8):2402-2414.
8[6]Christian S.Haas M,AsffAmin,et al.In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis[J].Arhtritis and Rheumatism,2007,56(8):2535-2548.
9[8]De BM,BenMM,Ollivier V.et al.Blockade of vascular endotheli al growth factor receptor I(VEGFR-I),but not VEGFR Ⅱ,suppresses joint destruction in the K/BxN model of rheumatoid arthritis[J].Immunol,2003.1712(9):4853-4859.
10[9]Yoo SA,Bae DG Ryoo Jw.et al.Aginine-Rich Anti-Vascular Endothelial Growth Factor(Anti-VEGF)Hexapeptide Inhibits Collagen-Induced Arthritis and VEGF-Stimulated Productions of TNF-αand IL-6 by HumaIl Monocytes[J].The Journal of Immunology,2005,174:5846-5855.
